The innovation at the service of development and the improvement of surgical interventions in peripheral arterial pathologies, also known as showcase disease, one of the most common among people over 50 years of age, but curiously underdiagnosed.
The Showcase disease it is the most common in people over 50 years old, however, 20% of patients are undiagnosedTherefore, on a recurring basis, hospital centers organize conferences to publicize both the disease and its risks, as well as to make the population aware of the importance of paying attention to the body and making the pertinent reviews that discover or prevent any pathology like this.
Showcase disease, the most common in people over 50 years of age
In this sense, the Angiology and Vascular and Endovascular Surgery Service of the Hospital Quirónsalud Málaga has performed complex live surgery on a patient with iliofemoropopliteal arterial pathology where, in addition, they were present around 200 angiologists and vascular surgeons to discuss technological innovations and new scientific evidence in the minimally invasive endovascular treatment of pathologies of veins and arteries.
The team of Dr. Alejandro Rodríguez Morata, from the facilities of the aforementioned hospital, has starred in the only live surgery training in which they have placed the patient “a new model Multi-LOC stent; smaller, faster and with fewer complications, as it is a multiple stent system ”, he explained.
«It is a tool that has several stents mounted in the same delivery catheter, so that mini stents can be applied in very specific areas of lesions; technique called spot stent, which allows leaving fewer implant areas in the arteries than what we have previously been doing with longer stents, thus achieving better results. In addition, this technique is faster, since the small stents are prepared on the same catheter and you do not have to change the system to treat all injuries at the same time, “said the specialist.
For this reason, he adds, “it is consolidated as a new effective tool, with very satisfactory results, for the specialized treatment of femoropopliteal vascular diseases ».
Vascular diseases: leading cause of female mortality
The vascular diseases, as we indicated previously, they are one of the main causes of death in the world. But, in addition, it should also be noted that it is the leading cause of female mortality and the second male, representing 30% of deaths in all Spain. That is to say, about 127,000 deaths annually.
The most common is Showcase disease which, in addition, affects up to 8.5% of the population over 55 years of age. Nevertheless, at least 20% of patients are undiagnosed. This high rate is due to the fact that it often occurs asymptomatic form or its symptoms are considered minor, since they are attributed to age, back problems, varicose veins, joint … But, detecting it early is very important, because PAD is also an important predictor of early mortality for its relationship with cardiovascular disease and cerebrovascular disease.
It is important to go to the angiologist and vascular surgeon
Hence the Endovascular Surgery Chapter of the Spanish Society of Angiology and Vascular Surgery (SEACV) has dedicated an open day to citizens in which they have addressed questions such as when and why it is important to go to the angiologist and vascular surgeon, what nutritional advice should be followed to prevent or mitigate PAD, what therapeutic exercise guidelines should be followed, what role play nursing consultations in the control of cardiovascular risk factors and what patient associations can do for people with vascular disease.
Thus, this and other pathologies have been debated in the round tables of the past congress in which the Angiology and Vascular Surgery Service together with internationally recognized surgeons. In this way, with the Dr. Alejandro Rodríguez Morata as moderator, the Dr. Fernando Gallardo, an angiologist at the Hospital Quirónsalud Málaga, has treated the PTSD (pulmonary thromboembolism) code; an action protocol with which some patients with pulmonary embolism undergo mechanical and chemical fibrinolysis as an emergency.
On the other hand, among others, the Dr. Tim Sebastian, from the University Hospital of Zurich, has commented whether venous compression syndromes are really rare diseases or are only underdiagnosed; Nabil Chakfe, professor of vascular surgery at the University Hospital of Strasbourg, has spoken of the new venous stent designs, especially for the left renal vein or the inguinal ligament; or the Dr. Houman Jalaile, from the RWTH University Hospital in Aachen, has explained the technical limits in recanalization of chronic iliofemoral venous occlusion.
In short, this meeting of world-class vascular surgeons to comment, debate and update on the latest techniques and advances for the treatment of all endovascular pathologies, also acquiring a more innovative character with the introduction of the training of new surgical techniques with live surgeries.
New President of the Endovascular Surgery Chapter
The Dr. Rodríguez Morata, head of the Angiology and Vascular Surgery Service of the Quirón Salud Hospital in Malaga He is already the new President of the Endovascular Surgery Chapter. His candidacy was imposed in the General Assembly held within the framework of the V International Congress of Endovascular Surgery to the one led by an opposing team.
The organization chart of the new Board of Directors is completed with Manuel Alonso Pérez, Head of Angiology, Vascular and Endovascular Surgery of the Central University Hospital of Asturias, who will be first vice president; Ignacio Agúndez Gómez, Head of Angiology, Vascular and Endovascular Surgery of the University Hospital of Burgos, who will be second vice president; Mª Lourdes del Río Solá, Head of Unit, Angiology, Vascular and Endovascular Surgery Service of the Valladolid University Hospital, who will be secretary; and Manel Arrebola López, Head of the Angiology, Vascular and Endovascular Surgery Unit, Hospital La Fe, Valencia, who will be treasurer.
The Information and Radioprotection committee will be filled by Lucas Mengíbar Fuentes, Head of the Angiology, Vascular and Endovascular Surgery Service of the Virgen del Rocío University Hospital, Seville; Endovascular Arterial Therapeutics in Aneurysms and Dissections, by José Miguel Zaragozá García, FEA of Angiology, Vascular and Endovascular Surgery of the Dr. Peset University Hospital, Valencia; that of Ischemic Arterial Endovascular Therapeutics, by Jordi Cordobés Gual, FEA of Angiology, Vascular and Endovascular Surgery of the Arnau de Vilanova University Hospital, Lérida; and that of Endovascular Therapeutics in Malformations, Tumors and Vascular Accesses, by Dr. Miguel Muela Méndez, FEA of Angiology, Vascular and Endovascular Surgery of the University Hospital of Guadalajara.